Regulatory Affairs (FDA/IND-enabling support)
Pharmaxi MRM Inc.provides comprehensive Regulatory Affairs support to guide biotech sponsors through the complex pathway toward FDA Investigational New Drug (IND) submission and global clinical trial authorization. Our regulatory specialists assist with strategy development, preparation of IND-enabling documentation, and coordination of preclinical, CMC, and clinical data required for regulatory filings. We support interactions with the U.S. FDA, including pre-IND meeting preparation, briefing documents, and regulatory correspondence. The team ensures compliance with ICH guidelines, FDA regulations, and international standards, helping sponsors structure development programs efficiently. By integrating regulatory planning early in the development process, Pharmaxi MRM Inc.accelerates approvals and reduces regulatory risk.
Clinical Operations at Pharmaxi MRM Inc.oversees the end-to-end execution of clinical trials, ensuring that studies are conducted efficiently, ethically, and in full compliance with international regulatory standards including FDA, EMA, and ICH-GCP guidelines. Our experienced clinical project managers, CRAs, and site specialists coordinate study start-up, site selection, monitoring, and close-out activities across global trial locations. Leveraging Pharmaxi’s long-standing clinical infrastructure and MRM BioEnt’s strategic oversight, we provide reliable patient recruitment, data quality assurance, and proactive risk management. Our operational model emphasizes transparency, strict timelines, and cost efficiency, enabling biotech sponsors to accelerate development programs while maintaining the highest standards of clinical research integrity.
Clinical Operations
Pharmaxi MRM Inc.provides integrated Data Management and Biostatistics services to ensure the accuracy, integrity, and regulatory compliance of clinical trial data. Our team designs and manages robust electronic data capture (EDC) systems, develops data management plans, and performs data validation, cleaning, and database lock procedures in accordance with ICH-GCP and FDA standards. Biostatistics experts support study design, sample size determination, statistical analysis planning, and generation of tables, listings, and figures (TLFs) for clinical study reports and regulatory submissions. Through rigorous quality control and advanced analytical methods, Pharmaxi MRM Inc.transforms complex clinical data into reliable evidence, enabling sponsors to make informed development decisions and successfully support regulatory approvals.
Data Management & Biostatistics
Pharmaxi MRM Inc.provides specialized medical writing services supporting all phases of clinical development and regulatory submission. Our experienced scientific writers prepare high-quality, regulatory-compliant documents including clinical study protocols, investigator brochures, clinical study reports (CSRs), IND modules, regulatory summaries, and scientific publications. Working closely with clinical, regulatory, and biostatistics teams, we ensure that complex scientific and clinical data are presented clearly, accurately, and in accordance with ICH, FDA, and EMA guidelines. Our structured document management process ensures consistency, traceability, and timely delivery of submission-ready materials. By combining scientific rigor with clear communication, Pharmaxi MRM Inc.helps sponsors efficiently present their data to regulators, investigators, and the scientific community.
Medical Writing
Pharmaxi MRM Inc.provides coordinated clinical supply and logistics management to ensure investigational products and trial materials are delivered reliably and on schedule to study sites worldwide. Our team manages forecasting, packaging, labeling, storage, and distribution of investigational medicinal products (IMPs) in accordance with GMP, GCP, and regulatory requirements. We oversee temperature-controlled transportation, import/export documentation, and customs clearance to maintain product integrity across international shipments. Integrated inventory tracking and supply planning help prevent shortages and minimize waste throughout the study lifecycle. By maintaining strict chain-of-custody procedures and proactive logistics planning, Pharmaxi MRM Inc.ensures that clinical trials proceed smoothly without supply disruptions.

Pharmaxi MRM Inc.provides comprehensive clinical supply and logistics services to ensure investigational medicinal products (IMPs) and trial materials are delivered efficiently and securely to clinical sites worldwide. Our team manages demand forecasting, packaging, labeling, storage, and global distribution in full compliance with GMP, GCP, and applicable regulatory requirements. We coordinate temperature-controlled transport, depot management, import/export documentation, and customs clearance to maintain product quality and regulatory compliance. Real-time inventory tracking and supply planning help optimize distribution and prevent shortages during study execution. Through rigorous chain-of-custody control and proactive logistics coordination, Pharmaxi MRM Inc.ensures uninterrupted trial operations and reliable support for global clinical programs.
Clinical Supply & Logistics
Pharmaxi MRM Inc.provides comprehensive pharmacovigilance and drug safety services to monitor, assess, and report the safety of investigational and marketed products throughout the clinical development lifecycle. Our safety team manages adverse event (AE) and serious adverse event (SAE) reporting, safety database management, medical review, and expedited reporting to regulatory authorities including the U.S. FDA and other global agencies. We prepare and maintain key safety documents such as Development Safety Update Reports (DSURs), Periodic Safety Update Reports (PSURs), and Risk Management Plans (RMPs). Operating under ICH-GCP and global pharmacovigilance guidelines, Pharmaxi MRM Inc.ensures continuous safety monitoring, rapid signal detection, and full regulatory compliance, helping sponsors protect patient safety and maintain regulatory confidence.
Pharmacovigilance / Safety
Pharmaxi MRM Inc.maintains a comprehensive Quality Management System (QMS) to ensure that all clinical research activities meet the highest standards of ICH-GCP, FDA, EMA, and international regulatory requirements. Our quality team develops and maintains standard operating procedures (SOPs), oversees quality control processes, and implements continuous improvement initiatives across all project phases. We conduct internal and external audits, including site audits, vendor audits, and study-specific quality reviews, to verify compliance and identify potential risks early. Through structured corrective and preventive action (CAPA) processes and ongoing training programs, Pharmaxi MRM Inc.ensures consistent operational excellence, regulatory readiness, and reliable clinical trial outcomes for sponsors and partners.
Quality Management & Audits
Made on
Tilda